← All companies

QDEL

QuidelOrtho Corporation

QDEL Nasdaq In Vitro & In Vivo Diagnostic Substances EDGAR ↗

$17.71

+0.94 +5.61%

Key statistics

from XBRL data in SEC filings

Market cap

$1.21B

Revenue (TTM)

$2.66B

Net income (TTM)

-$1.21B

EPS (TTM)

$-17.85

P/E ratio

—

Dividend yield

—

Free cash flow

-$83.0M

Cash

$140M

Total assets

$5.63B

Gross margin

—

52-week range

$9.92 – $35.58

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Director or officer change; Regulation FD disclosure Jun 23, 2026 8-K Shareholder vote results Jun 16, 2026 10-Q Quarter ended 2026-03-29 May 6, 2026 8-K Results of operations (earnings release) May 5, 2026 8-K Results of operations (earnings release) Apr 15, 2026 8-K Director or officer change; Regulation FD disclosure Mar 24, 2026 10-K Fiscal year ended 2025-12-28 Feb 19, 2026 8-K Director or officer change Feb 13, 2026 8-K Results of operations (earnings release) Feb 11, 2026 8-K Director or officer change Feb 5, 2026 8-K Regulation FD disclosure Nov 10, 2025 10-Q Quarter ended 2025-09-28 Nov 6, 2025 8-K Results of operations (earnings release) Nov 5, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Other events Aug 21, 2025 10-Q Quarter ended 2025-06-29 Aug 6, 2025 8-K Results of operations (earnings release) Aug 5, 2025 8-K Director or officer change; Shareholder vote results May 27, 2025 10-Q Quarter ended 2025-03-30 May 8, 2025 8-K Results of operations (earnings release) May 7, 2025 8-K Changed accountants Mar 4, 2025 10-K Fiscal year ended 2024-12-29 Feb 27, 2025 8-K Results of operations (earnings release) Feb 12, 2025 8-K Results of operations (earnings release) Jan 13, 2025 8-K Director or officer change Dec 10, 2024 8-K Director or officer change; Other events Nov 21, 2024 8-K Director or officer change Nov 18, 2024 8-K/A Director or officer change Nov 18, 2024 8-K Director or officer change Nov 8, 2024 10-Q Quarter ended 2024-09-29 Nov 8, 2024 8-K Results of operations (earnings release) Nov 7, 2024 10-Q Quarter ended 2024-06-30 Aug 1, 2024 10-K/A Fiscal year ended 2023-12-31 Aug 1, 2024 8-K Results of operations (earnings release) Jul 31, 2024 8-K Shareholder vote results May 17, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Results of operations (earnings release) May 8, 2024 8-K Director or officer change; Regulation FD disclosure May 7, 2024 8-K Entered a material agreement Apr 29, 2024 8-K/A Director or officer change Feb 29, 2024 10-K Fiscal year ended 2023-12-31 Feb 29, 2024